The Importance of Regulating E-Cigarettes in Ireland

Jul.31.2022
The Importance of Regulating E-Cigarettes in Ireland
The Irish tobacco policy group chair supports restricting e-cigarettes to promote public health and reduce teen smoking.

Professor Des Cox, the chairman of the Irish Tobacco Policy Group, has commented on the recent opinion piece in the Wall Street Journal titled "Why We Shouldn't Wage War on E-cigarettes", stating that he believes such a battle should indeed be fought.


In 2013, the government launched a bold plan to reduce Ireland's smoking rate to 5% by 2025, ushering in a smoke-free society. As of 2021, however, 18% of Irish adults are still smokers, rendering this ambitious goal unattainable.


Last week's opinion piece argued that Ireland needs to embrace e-cigarettes to help more people quit smoking, but is there evidence to support this approach?


The Oireachtas Health Committee has released a report on the Public Health (Tobacco and Nicotine Inhaling Products) Bill. In addition to recommending a ban on the sale of electronic cigarettes to those under 18, the committee also suggested prohibiting the sale of all flavors except tobacco, introducing plain packaging, and banning all forms of e-cigarette advertising.


Teenagers


The first issue to be addressed is the relationship between electronic cigarettes and youth. According to the findings report from the European School Survey Project on Alcohol and Other Drugs (ESPAD) released by the TobaccoFree Research Institute in 2020, the use of electronic cigarettes by 16-17 year-olds has increased by 50% since 2015.


According to a recent survey by ASH UK, 39% of teenagers have tried e-cigarettes and 18% are current users. The study also found that the number of children aged 11 to 17 who use e-cigarettes has increased from 11.2% in 2021 to 15.7% in 2022.


Of concern is the simultaneous increase in the use of electronic cigarettes and the consumption of disposable e-cigarette products by young people. According to a report, the use of disposable e-cigarettes by this age group has increased seven-fold from 2020 to 2022. Nearly half of the surveyed teenagers reported seeing e-cigarette promotion and specifically on TikTok. There is an urgent need to strengthen regulations around the marketing of e-cigarettes, especially online marketing.


Last week's article raised concerns that banning flavored e-cigarettes would result in an increase in Ireland's smoking population. However, there is no publicly available evidence to support this claim. On the other hand, there is substantial evidence indicating that flavored products attract young people to purchase them, leading them to believe that e-cigarettes are a harmless product.


Although adults may also be attracted to flavored electronic cigarettes, the risks of teenagers and young people starting to use them may outweigh the benefits of former smokers using flavored electronic cigarettes.


Last week's article claimed that vaping is a gateway to smoking. A comprehensive study on the topic has found that teenagers who have used e-cigarettes are three to five times more likely to start smoking compared to those who have never used e-cigarettes.


There is now irrefutable evidence that we must protect children from the lure of smoking and e-cigarettes. Simply banning the sale of e-cigarettes to children under the age of 18 through the proposed public health bill will not be the ultimate solution; government officials need to consider the recommendations of the Oireachtas committee on the bill.


Based on the available evidence, we suggest that electronic cigarettes should be subject to the same packaging, advertising, and marketing restrictions as traditional tobacco products. Ireland should only allow tobacco-flavored e-cigarettes, which would enable former smokers to continue experiencing the taste of tobacco while limiting their use among adolescents and young adults.


Last year, a systematic review was published which analyzed ten randomized controlled trials to investigate whether electronic cigarettes were an effective tool for smoking cessation. The review found no evidence to suggest that electronic cigarettes were more effective than nicotine replacement therapy (NRT), which is approved and regulated for smoking cessation.


The evidence for electronic cigarettes as a tool for quitting smoking is at best mixed, and healthcare professionals should recommend reliable methods such as NRT that have been proven effective through practice, rather than electronic cigarettes. In January, Ireland released its first national smoking cessation guidelines, which did not recommend electronic cigarettes as a tool for quitting smoking due to insufficient evidence and the uncertainty surrounding these products.


Best advice.


In addition, healthcare professionals need to have confidence that the treatments they recommend to patients are safe in order to suggest effective methods of care. In 2020, the Health Research Council conducted a review of over 361 studies on the risks and benefits of e-cigarettes and found that they have negative effects on the heart and lungs.


Some supporters of using e-cigarettes as a tool to quit smoking claim that they are 95% safer than tobacco products. However, this statement lacks scientific evidence and is based on the opinions of a small group of doctors from 2013, when we knew little about the harmful effects of e-cigarettes. While it is important to acknowledge that e-cigarettes pose less harm than tobacco products, they are not without risk and the public needs to be aware of this fact.


The argument that e-cigarettes reduce harm has been overemphasized, as they are not more effective than validated treatment methods, and there is too much uncertainty regarding their long-term safety. Additionally, research indicates that many e-cigarette users continue smoking. The 2018 Healthy Ireland survey revealed that 4 out of every 10 adults who use e-cigarettes also use traditional cigarettes.


In order for electronic cigarettes to become a viable option in harm reduction strategies, they must prove themselves as safe products regulated by the Health Products Regulatory Authority (HPRA) to aid people in quitting smoking.


In summary, the evidence in 2022 does not support the argument that electronic cigarettes are an effective tool for quitting smoking. Their long-term safety is still a cause for serious concern and it has been proven that they are a gateway to smoking for teenagers.


Until more conclusive research becomes available, healthcare professionals should promote safe and effective smoking cessation methods, such as nicotine replacement therapy (NRT), rather than unproven methods like electronic cigarettes. The good news is that most smokers want to quit, and there is help available. The HSE's www.quit.ie service is staffed by experienced and trained professionals who offer validated smoking cessation assistance.


Note: Professor Des Cox serves as the Chair of the Tobacco Policy Group at the Royal College of Physicians of Ireland and as a Respiratory Medicine Consultant at Crumlin Children's Hospital in Ireland.


I am sorry, as an AI language model, I only perform tasks based on a specific prompt or request. Please provide me with the text that needs to be translated to standard journalistic English.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10